We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$140B
AUM Growth
+$5.37B
Cap. Flow
+$13.5B
Cap. Flow %
9.64%
Top 10 Hldgs %
30.28%
Holding
6,714
New
321
Increased
2,151
Reduced
2,607
Closed
759

Sector Composition

Rank Sector Weight
1 Technology 8.94%
2 Healthcare 5.53%
3 Financials 5.03%
4 Consumer Discretionary 4.6%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYLT
5526
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$1K ﹤0.01%
844
-15,097
-95% -$39.2K
RAAS
5527
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$1K ﹤0.01%
581
SFT
5528
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$1K ﹤0.01%
181
-774
-81% -$7.42K
RUBY
5529
DELISTED
Rubius Therapeutics, Inc
RUBY
$1K ﹤0.01%
1,286
-692
-35% -$519
ITQRW
5530
CALL
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$1K ﹤0.01%
19,001
ATNX
5531
DELISTED
Athenex, Inc. Common Stock
ATNX
$1K ﹤0.01%
96
-35
-27% -$360
SCOBW
5532
CALL
DELISTED
ScION Tech Growth II Warrants
SCOBW
$1K ﹤0.01%
19,989
ARCKW
5533
CALL
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
$1K ﹤0.01%
14,266
KAIRW
5534
CALL
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1K ﹤0.01%
37,351
CLAS.U
5535
DELISTED
Class Acceleration Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
CLAS.U
$1K ﹤0.01%
100
HCICW
5536
CALL
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$1K ﹤0.01%
8,795
HCIIW
5537
CALL
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$1K ﹤0.01%
25,001
HIIIW
5538
CALL
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$1K ﹤0.01%
15,001
VELOW
5539
CALL
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$1K ﹤0.01%
8,870
RCOR
5540
DELISTED
Renovacor, Inc.
RCOR
$1K ﹤0.01%
+401
New +$768
STON
5541
DELISTED
StoneMor Inc.
STON
$1K ﹤0.01%
415
-1,635
-80% -$5.61K
TMAC.WS
5542
CALL
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$1K ﹤0.01%
35,046
HYMCZ
5543
CALL
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$1K ﹤0.01%
15,290
SBII.WS
5544
CALL
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$1K ﹤0.01%
16,667
HTAQ.WS
5545
CALL
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
$1K ﹤0.01%
25,301
GBL
5546
DELISTED
GAMCO Investors, Inc.
GBL
$1K ﹤0.01%
72
-248
-78% -$5K
PLM
5547
DELISTED
PolyMet Mining Corp.
PLM
$1K ﹤0.01%
443
-1,661
-79% -$4.96K
SBDS
5548
DELISTED
Solo Brands Inc
SBDS
$1K ﹤0.01%
8
-108
-93% -$20.2K
ACAD icon
5549
CALL
Acadia Pharmaceuticals
ACAD
$4.35B
-25,000
Closed -$352K
ACAD icon
5550
PUT
Acadia Pharmaceuticals
ACAD
$4.35B
-25,000
Closed -$352K

Similar funds

Citigroup's Q3 2022 Portfolio in Review

As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.

  • Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
  • Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
  • Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
  • Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
  • Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
  • Citigroup opened 321 new positions and closed 759 in Q3 2022.
  • Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.